OBJECTIVE: Adult epiglottitis is a potentially life-threatening infection and its reported incidence has not decreased since widespread H. influenzae Type B vaccination. Our study aims to review the presentation, management and outcome of epiglottitis in 169 adults admitted to Liverpool Hospital, Sydney, Australia, between January 1999 to January 2009. METHOD: Retrospective case note review was conducted on all admissions with epiglottitis in patients aged 18 and above as identified from the hospital admissions database. All patients were reviewed by an ENT registrar or consultant and the diagnosis was confirmed by fiberoptic nasolaryngoscopy or direct laryngoscopy under general anesthetic. The main out-come measure was the need for intubation or tracheotomy. Univariate analysis was performed to determine factors that led to a worse outcome. RESULTS: There were 80 males and 89 females in the cohort, with a median age of 51 years (range 18 to 74). The common symptoms and signs at presentation were odynophagia and dysphagia (94%), dysphonia (65%), and stridor (33%). Endotracheal intubation was performed in 16 (10%) patients and an awake tracheotomy was required in 4 (2%) patients. Blood cultures were performed in 97 (57%) patients but positive findings were present in only 12 (7%). Seven cultures were positive for H. influenzae, 3 for S. pneumoniae and 2 for S. aureus. Cefriaxone and flucoxacillin was the most common antibiotic combination used. Dexamethasone was used in 103 patients (61%). 35 patients (20%) had diabetes mellitus as a comorbidity and 3 were immunocompromised. There was no mortality and the average length of stay in hospital was 5 days (range 3-9). 140 patients (82%) were admitted to ICU for an mean duration of 2 days(range 1-5). On univariate analysis, the presence of diabetes was found to be predictive of the need for intubation or tracheotomy (pϽ0.05). CONCLUSION: Adult epiglottitis needs to be suspected in patients with no direct visible cause of odynophagia. Fiberoptic laryngoscopy is the gold standard for diagnosis and close airway monitoring is crucial. Conservative management of the airway is a viable option but the presence of diabetes makes airway intervention more likely. The use of steroids aids in symptom alleviation and hastening resolution of airway swelling with no negative sequelae.
Alpha-1-Blockers for Obstructive Salivary Gland Diseases
Philippe Katz, MD (presenter) OBJECTIVE: Alpha-blockers are widely used in urology as an aid in treating stenosis and lithiasis. A similar pathophysiology is encountered in the salivary gland, and alpha-1 adrenoreceptors have been shown to exist in salivary ducts. The aim of our study was to evaluate the safety and effectiveness of alpha-blockers in treating obstructive salivary gland diseases. METHOD: Retrospective study over 3 years of patients with ductal stenosis, allergic pseudo-parotitis or sialolithiasis after lithotripsy in the parotid or submandibular glands. Male patients were given 2.5 mg bid of the alpha-blocker alfuzosin and female patients 2.5 mg bid. At 3 months, ultrasound was performed and a subjective evaluation of symptoms was obtained via a questionnaire. RESULTS: 352 patients were treated for 3 to 24 months (average 8 months). Twelve patients (3.4%) reported adverse effects (orthostatic hypotension, cutaneous allergy, dysejaculation, dysuria) and 10 (2.8%) stopped the treatment after 3 months. A large subjective improvement in symptoms was reported by 80% of the 69 patients with stenosis, 79% of the 89 with allergic pseudo-parotitis, and 67% of the 112 with resid-
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